First Horizon Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

First Horizon Advisors’s Portfolio SBIO Stock Details SBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-195	Closed	-$7K	–	2202
2021 Q4	$7K	Hold	195	–	–	﹤0.01%	1661
2021 Q3	$8K	Buy	195 +175	+875%	+$8.03K	﹤0.01%	1619
2021 Q2	$0	Hold	20	–	–	﹤0.01%	2075
2021 Q1	$1K	Buy	+20	New	+$1.11K	﹤0.01%	1804

Other funds holding SBIO

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Matisse Capital Portland, Oregon $234M AUM 19.72% 1-Year Est. Return

NAM

NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

BPA

Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

First Horizon Advisors's SBIO Position: Q1 2022 in Review

First Horizon Advisors sold out of ALPS Medical Breakthroughs ETF (SBIO) in Q1 2022, closing a stake of 195 shares — an estimated $7K sold.

First Horizon Advisors first reported a position in SBIO in Q1 2021 and held it in 4 quarters. The position peaked at $8K in Q3 2021. 56 funds tracked by Wall St. Rank hold SBIO as of Q1 2022.

First Horizon Advisors reported no remaining ALPS Medical Breakthroughs ETF position as of Q1 2022 after selling out during the quarter.
First Horizon Advisors sold 195 ALPS Medical Breakthroughs ETF shares in Q1 2022, an estimated $7K.
First Horizon Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q1 2021 and held it in 4 quarters.
First Horizon Advisors's ALPS Medical Breakthroughs ETF position peaked at $8K in Q3 2021.
56 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q1 2022.

Based on First Horizon Advisors's 13F filing for Q1 2022, filed 10 May 2022.